nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—NR3C1—glaucoma	0.448	1	CbGaD
Mifepristone—CYP2D6—Carteolol—glaucoma	0.0525	0.154	CbGbCtD
Mifepristone—CYP2D6—Betaxolol—glaucoma	0.0354	0.104	CbGbCtD
Mifepristone—CYP3A5—Clonidine—glaucoma	0.0317	0.0929	CbGbCtD
Mifepristone—CYP2D6—Methazolamide—glaucoma	0.0269	0.0788	CbGbCtD
Mifepristone—CYP3A4—Pilocarpine—glaucoma	0.0253	0.0742	CbGbCtD
Mifepristone—ABCB1—Timolol—glaucoma	0.0242	0.0711	CbGbCtD
Mifepristone—CYP2D6—Timolol—glaucoma	0.0228	0.067	CbGbCtD
Mifepristone—ABCB1—Clonidine—glaucoma	0.0206	0.0605	CbGbCtD
Mifepristone—CYP3A4—Brinzolamide—glaucoma	0.0198	0.0582	CbGbCtD
Mifepristone—CYP2D6—Clonidine—glaucoma	0.0194	0.057	CbGbCtD
Mifepristone—CYP3A4—Dorzolamide—glaucoma	0.0192	0.0562	CbGbCtD
Mifepristone—CYP3A4—Methazolamide—glaucoma	0.0171	0.0501	CbGbCtD
Mifepristone—CYP3A4—Acetazolamide—glaucoma	0.0137	0.0401	CbGbCtD
Mifepristone—CYP3A4—Clonidine—glaucoma	0.0123	0.0362	CbGbCtD
Mifepristone—Hypotension—Dorzolamide—glaucoma	0.000306	0.00159	CcSEcCtD
Mifepristone—Dyspnoea—Brimonidine—glaucoma	0.000306	0.00159	CcSEcCtD
Mifepristone—Somnolence—Brimonidine—glaucoma	0.000305	0.00159	CcSEcCtD
Mifepristone—Mental disorder—Clonidine—glaucoma	0.000305	0.00158	CcSEcCtD
Mifepristone—Hypotension—Travoprost—glaucoma	0.000305	0.00158	CcSEcCtD
Mifepristone—Hypotension—Brinzolamide—glaucoma	0.000301	0.00156	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000299	0.00155	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Travoprost—glaucoma	0.000297	0.00154	CcSEcCtD
Mifepristone—Insomnia—Dorzolamide—glaucoma	0.000297	0.00154	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Brimonidine—glaucoma	0.000296	0.00154	CcSEcCtD
Mifepristone—Fatigue—Brimonidine—glaucoma	0.000296	0.00154	CcSEcCtD
Mifepristone—Anorexia—Pilocarpine—glaucoma	0.000295	0.00153	CcSEcCtD
Mifepristone—Feeling abnormal—Acetazolamide—glaucoma	0.000295	0.00153	CcSEcCtD
Mifepristone—Hypersensitivity—Apraclonidine—glaucoma	0.000295	0.00153	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000294	0.00153	CcSEcCtD
Mifepristone—Pain—Brimonidine—glaucoma	0.000294	0.00152	CcSEcCtD
Mifepristone—Dyspnoea—Dorzolamide—glaucoma	0.000292	0.00152	CcSEcCtD
Mifepristone—Insomnia—Brinzolamide—glaucoma	0.000292	0.00151	CcSEcCtD
Mifepristone—Somnolence—Dorzolamide—glaucoma	0.000291	0.00151	CcSEcCtD
Mifepristone—Muscle spasms—Clonidine—glaucoma	0.000291	0.00151	CcSEcCtD
Mifepristone—Dyspnoea—Travoprost—glaucoma	0.000291	0.00151	CcSEcCtD
Mifepristone—Hypotension—Pilocarpine—glaucoma	0.000289	0.0015	CcSEcCtD
Mifepristone—Dyspnoea—Brinzolamide—glaucoma	0.000287	0.00149	CcSEcCtD
Mifepristone—Asthenia—Apraclonidine—glaucoma	0.000287	0.00149	CcSEcCtD
Mifepristone—Somnolence—Brinzolamide—glaucoma	0.000287	0.00149	CcSEcCtD
Mifepristone—Decreased appetite—Dorzolamide—glaucoma	0.000285	0.00148	CcSEcCtD
Mifepristone—Urticaria—Acetazolamide—glaucoma	0.000284	0.00148	CcSEcCtD
Mifepristone—Pruritus—Apraclonidine—glaucoma	0.000283	0.00147	CcSEcCtD
Mifepristone—Body temperature increased—Acetazolamide—glaucoma	0.000283	0.00147	CcSEcCtD
Mifepristone—Fatigue—Dorzolamide—glaucoma	0.000283	0.00147	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000282	0.00147	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Travoprost—glaucoma	0.000282	0.00146	CcSEcCtD
Mifepristone—Fatigue—Travoprost—glaucoma	0.000281	0.00146	CcSEcCtD
Mifepristone—Ill-defined disorder—Clonidine—glaucoma	0.000281	0.00146	CcSEcCtD
Mifepristone—Pain—Dorzolamide—glaucoma	0.00028	0.00146	CcSEcCtD
Mifepristone—Insomnia—Pilocarpine—glaucoma	0.00028	0.00146	CcSEcCtD
Mifepristone—Decreased appetite—Brinzolamide—glaucoma	0.00028	0.00146	CcSEcCtD
Mifepristone—Pain—Travoprost—glaucoma	0.000279	0.00145	CcSEcCtD
Mifepristone—Constipation—Travoprost—glaucoma	0.000279	0.00145	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000278	0.00145	CcSEcCtD
Mifepristone—Asthenia—Bimatoprost—glaucoma	0.000278	0.00144	CcSEcCtD
Mifepristone—Fatigue—Brinzolamide—glaucoma	0.000278	0.00144	CcSEcCtD
Mifepristone—Angioedema—Clonidine—glaucoma	0.000277	0.00144	CcSEcCtD
Mifepristone—Dyspnoea—Pilocarpine—glaucoma	0.000276	0.00143	CcSEcCtD
Mifepristone—Pain—Brinzolamide—glaucoma	0.000276	0.00143	CcSEcCtD
Mifepristone—Somnolence—Pilocarpine—glaucoma	0.000275	0.00143	CcSEcCtD
Mifepristone—Angiopathy—Betaxolol—glaucoma	0.000275	0.00143	CcSEcCtD
Mifepristone—Pruritus—Bimatoprost—glaucoma	0.000274	0.00142	CcSEcCtD
Mifepristone—Diarrhoea—Apraclonidine—glaucoma	0.000274	0.00142	CcSEcCtD
Mifepristone—Malaise—Clonidine—glaucoma	0.000273	0.00142	CcSEcCtD
Mifepristone—Mediastinal disorder—Betaxolol—glaucoma	0.000273	0.00142	CcSEcCtD
Mifepristone—Chills—Betaxolol—glaucoma	0.000272	0.00141	CcSEcCtD
Mifepristone—Feeling abnormal—Dorzolamide—glaucoma	0.00027	0.0014	CcSEcCtD
Mifepristone—Decreased appetite—Pilocarpine—glaucoma	0.000269	0.0014	CcSEcCtD
Mifepristone—Feeling abnormal—Travoprost—glaucoma	0.000269	0.0014	CcSEcCtD
Mifepristone—Gastrointestinal pain—Dorzolamide—glaucoma	0.000268	0.00139	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000267	0.00139	CcSEcCtD
Mifepristone—Gastrointestinal pain—Travoprost—glaucoma	0.000267	0.00139	CcSEcCtD
Mifepristone—Feeling abnormal—Brinzolamide—glaucoma	0.000266	0.00138	CcSEcCtD
Mifepristone—Mental disorder—Betaxolol—glaucoma	0.000266	0.00138	CcSEcCtD
Mifepristone—Constipation—Pilocarpine—glaucoma	0.000265	0.00138	CcSEcCtD
Mifepristone—Pain—Pilocarpine—glaucoma	0.000265	0.00138	CcSEcCtD
Mifepristone—Dizziness—Apraclonidine—glaucoma	0.000264	0.00137	CcSEcCtD
Mifepristone—Malnutrition—Betaxolol—glaucoma	0.000264	0.00137	CcSEcCtD
Mifepristone—Urticaria—Dorzolamide—glaucoma	0.00026	0.00135	CcSEcCtD
Mifepristone—Abdominal pain—Dorzolamide—glaucoma	0.000259	0.00135	CcSEcCtD
Mifepristone—Body temperature increased—Dorzolamide—glaucoma	0.000259	0.00135	CcSEcCtD
Mifepristone—Sinusitis—Timolol—glaucoma	0.000259	0.00134	CcSEcCtD
Mifepristone—Arthralgia—Clonidine—glaucoma	0.000258	0.00134	CcSEcCtD
Mifepristone—Abdominal pain—Travoprost—glaucoma	0.000258	0.00134	CcSEcCtD
Mifepristone—Anxiety—Clonidine—glaucoma	0.000257	0.00134	CcSEcCtD
Mifepristone—Asthenia—Acetazolamide—glaucoma	0.000257	0.00133	CcSEcCtD
Mifepristone—Dizziness—Bimatoprost—glaucoma	0.000256	0.00133	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000256	0.00133	CcSEcCtD
Mifepristone—Urticaria—Brinzolamide—glaucoma	0.000256	0.00133	CcSEcCtD
Mifepristone—Feeling abnormal—Pilocarpine—glaucoma	0.000255	0.00133	CcSEcCtD
Mifepristone—Discomfort—Clonidine—glaucoma	0.000255	0.00132	CcSEcCtD
Mifepristone—Vomiting—Apraclonidine—glaucoma	0.000254	0.00132	CcSEcCtD
Mifepristone—Muscle spasms—Betaxolol—glaucoma	0.000254	0.00132	CcSEcCtD
Mifepristone—Gastrointestinal pain—Pilocarpine—glaucoma	0.000253	0.00132	CcSEcCtD
Mifepristone—Hypersensitivity—Brimonidine—glaucoma	0.000253	0.00131	CcSEcCtD
Mifepristone—Dry mouth—Clonidine—glaucoma	0.000252	0.00131	CcSEcCtD
Mifepristone—Dermatitis—Apraclonidine—glaucoma	0.000252	0.00131	CcSEcCtD
Mifepristone—Headache—Apraclonidine—glaucoma	0.00025	0.0013	CcSEcCtD
Mifepristone—Oedema—Clonidine—glaucoma	0.000247	0.00129	CcSEcCtD
Mifepristone—Asthenia—Brimonidine—glaucoma	0.000246	0.00128	CcSEcCtD
Mifepristone—Infection—Clonidine—glaucoma	0.000246	0.00128	CcSEcCtD
Mifepristone—Abdominal pain—Pilocarpine—glaucoma	0.000245	0.00127	CcSEcCtD
Mifepristone—Body temperature increased—Pilocarpine—glaucoma	0.000245	0.00127	CcSEcCtD
Mifepristone—Ill-defined disorder—Betaxolol—glaucoma	0.000245	0.00127	CcSEcCtD
Mifepristone—Diarrhoea—Acetazolamide—glaucoma	0.000245	0.00127	CcSEcCtD
Mifepristone—Rash—Bimatoprost—glaucoma	0.000244	0.00127	CcSEcCtD
Mifepristone—Dermatitis—Bimatoprost—glaucoma	0.000244	0.00127	CcSEcCtD
Mifepristone—Oedema peripheral—Timolol—glaucoma	0.000244	0.00127	CcSEcCtD
Mifepristone—Connective tissue disorder—Timolol—glaucoma	0.000243	0.00126	CcSEcCtD
Mifepristone—Pruritus—Brimonidine—glaucoma	0.000243	0.00126	CcSEcCtD
Mifepristone—Headache—Bimatoprost—glaucoma	0.000243	0.00126	CcSEcCtD
Mifepristone—Nervous system disorder—Clonidine—glaucoma	0.000243	0.00126	CcSEcCtD
Mifepristone—Hypersensitivity—Dorzolamide—glaucoma	0.000242	0.00125	CcSEcCtD
Mifepristone—Hypersensitivity—Travoprost—glaucoma	0.000241	0.00125	CcSEcCtD
Mifepristone—Skin disorder—Clonidine—glaucoma	0.00024	0.00125	CcSEcCtD
Mifepristone—Malaise—Betaxolol—glaucoma	0.000238	0.00124	CcSEcCtD
Mifepristone—Nausea—Apraclonidine—glaucoma	0.000238	0.00123	CcSEcCtD
Mifepristone—Hypersensitivity—Brinzolamide—glaucoma	0.000237	0.00123	CcSEcCtD
Mifepristone—Dizziness—Acetazolamide—glaucoma	0.000237	0.00123	CcSEcCtD
Mifepristone—Anorexia—Clonidine—glaucoma	0.000236	0.00122	CcSEcCtD
Mifepristone—Asthenia—Dorzolamide—glaucoma	0.000235	0.00122	CcSEcCtD
Mifepristone—Asthenia—Travoprost—glaucoma	0.000234	0.00122	CcSEcCtD
Mifepristone—Pruritus—Dorzolamide—glaucoma	0.000232	0.0012	CcSEcCtD
Mifepristone—Asthenia—Brinzolamide—glaucoma	0.000231	0.0012	CcSEcCtD
Mifepristone—Hypotension—Clonidine—glaucoma	0.000231	0.0012	CcSEcCtD
Mifepristone—Pruritus—Travoprost—glaucoma	0.000231	0.0012	CcSEcCtD
Mifepristone—Nausea—Bimatoprost—glaucoma	0.00023	0.0012	CcSEcCtD
Mifepristone—Hypersensitivity—Pilocarpine—glaucoma	0.000228	0.00119	CcSEcCtD
Mifepristone—Pruritus—Brinzolamide—glaucoma	0.000228	0.00118	CcSEcCtD
Mifepristone—Vomiting—Acetazolamide—glaucoma	0.000227	0.00118	CcSEcCtD
Mifepristone—Dizziness—Brimonidine—glaucoma	0.000227	0.00118	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Clonidine—glaucoma	0.000225	0.00117	CcSEcCtD
Mifepristone—Angiopathy—Timolol—glaucoma	0.000225	0.00117	CcSEcCtD
Mifepristone—Arthralgia—Betaxolol—glaucoma	0.000225	0.00117	CcSEcCtD
Mifepristone—Myalgia—Betaxolol—glaucoma	0.000225	0.00117	CcSEcCtD
Mifepristone—Diarrhoea—Dorzolamide—glaucoma	0.000224	0.00117	CcSEcCtD
Mifepristone—Headache—Acetazolamide—glaucoma	0.000224	0.00116	CcSEcCtD
Mifepristone—Anxiety—Betaxolol—glaucoma	0.000224	0.00116	CcSEcCtD
Mifepristone—Insomnia—Clonidine—glaucoma	0.000224	0.00116	CcSEcCtD
Mifepristone—Diarrhoea—Travoprost—glaucoma	0.000223	0.00116	CcSEcCtD
Mifepristone—Mediastinal disorder—Timolol—glaucoma	0.000223	0.00116	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000223	0.00116	CcSEcCtD
Mifepristone—Asthenia—Pilocarpine—glaucoma	0.000222	0.00115	CcSEcCtD
Mifepristone—Discomfort—Betaxolol—glaucoma	0.000222	0.00115	CcSEcCtD
Mifepristone—Dyspnoea—Clonidine—glaucoma	0.000221	0.00115	CcSEcCtD
Mifepristone—Diarrhoea—Brinzolamide—glaucoma	0.000221	0.00115	CcSEcCtD
Mifepristone—Somnolence—Clonidine—glaucoma	0.00022	0.00114	CcSEcCtD
Mifepristone—Dry mouth—Betaxolol—glaucoma	0.00022	0.00114	CcSEcCtD
Mifepristone—Pruritus—Pilocarpine—glaucoma	0.000219	0.00114	CcSEcCtD
Mifepristone—Mental disorder—Timolol—glaucoma	0.000217	0.00113	CcSEcCtD
Mifepristone—Dizziness—Dorzolamide—glaucoma	0.000217	0.00113	CcSEcCtD
Mifepristone—Rash—Brimonidine—glaucoma	0.000216	0.00112	CcSEcCtD
Mifepristone—Dermatitis—Brimonidine—glaucoma	0.000216	0.00112	CcSEcCtD
Mifepristone—Dizziness—Travoprost—glaucoma	0.000216	0.00112	CcSEcCtD
Mifepristone—Malnutrition—Timolol—glaucoma	0.000216	0.00112	CcSEcCtD
Mifepristone—Oedema—Betaxolol—glaucoma	0.000215	0.00112	CcSEcCtD
Mifepristone—Headache—Brimonidine—glaucoma	0.000215	0.00112	CcSEcCtD
Mifepristone—Decreased appetite—Clonidine—glaucoma	0.000215	0.00112	CcSEcCtD
Mifepristone—Infection—Betaxolol—glaucoma	0.000214	0.00111	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Clonidine—glaucoma	0.000214	0.00111	CcSEcCtD
Mifepristone—Fatigue—Clonidine—glaucoma	0.000213	0.00111	CcSEcCtD
Mifepristone—Dizziness—Brinzolamide—glaucoma	0.000213	0.00111	CcSEcCtD
Mifepristone—Nausea—Acetazolamide—glaucoma	0.000212	0.0011	CcSEcCtD
Mifepristone—Diarrhoea—Pilocarpine—glaucoma	0.000212	0.0011	CcSEcCtD
Mifepristone—Pain—Clonidine—glaucoma	0.000212	0.0011	CcSEcCtD
Mifepristone—Constipation—Clonidine—glaucoma	0.000212	0.0011	CcSEcCtD
Mifepristone—Nervous system disorder—Betaxolol—glaucoma	0.000211	0.0011	CcSEcCtD
Mifepristone—Skin disorder—Betaxolol—glaucoma	0.000209	0.00109	CcSEcCtD
Mifepristone—Vomiting—Dorzolamide—glaucoma	0.000208	0.00108	CcSEcCtD
Mifepristone—Rash—Dorzolamide—glaucoma	0.000207	0.00107	CcSEcCtD
Mifepristone—Dermatitis—Dorzolamide—glaucoma	0.000207	0.00107	CcSEcCtD
Mifepristone—Rash—Travoprost—glaucoma	0.000206	0.00107	CcSEcCtD
Mifepristone—Dermatitis—Travoprost—glaucoma	0.000206	0.00107	CcSEcCtD
Mifepristone—Headache—Dorzolamide—glaucoma	0.000205	0.00107	CcSEcCtD
Mifepristone—Anorexia—Betaxolol—glaucoma	0.000205	0.00107	CcSEcCtD
Mifepristone—Vomiting—Brinzolamide—glaucoma	0.000205	0.00106	CcSEcCtD
Mifepristone—Dizziness—Pilocarpine—glaucoma	0.000205	0.00106	CcSEcCtD
Mifepristone—Headache—Travoprost—glaucoma	0.000204	0.00106	CcSEcCtD
Mifepristone—Nausea—Brimonidine—glaucoma	0.000204	0.00106	CcSEcCtD
Mifepristone—Feeling abnormal—Clonidine—glaucoma	0.000204	0.00106	CcSEcCtD
Mifepristone—Rash—Brinzolamide—glaucoma	0.000203	0.00106	CcSEcCtD
Mifepristone—Dermatitis—Brinzolamide—glaucoma	0.000203	0.00105	CcSEcCtD
Mifepristone—Gastrointestinal pain—Clonidine—glaucoma	0.000202	0.00105	CcSEcCtD
Mifepristone—Headache—Brinzolamide—glaucoma	0.000202	0.00105	CcSEcCtD
Mifepristone—Hypotension—Betaxolol—glaucoma	0.000201	0.00105	CcSEcCtD
Mifepristone—Angioedema—Timolol—glaucoma	0.000197	0.00102	CcSEcCtD
Mifepristone—Vomiting—Pilocarpine—glaucoma	0.000197	0.00102	CcSEcCtD
Mifepristone—Urticaria—Clonidine—glaucoma	0.000197	0.00102	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000196	0.00102	CcSEcCtD
Mifepristone—Body temperature increased—Clonidine—glaucoma	0.000196	0.00102	CcSEcCtD
Mifepristone—Abdominal pain—Clonidine—glaucoma	0.000196	0.00102	CcSEcCtD
Mifepristone—Rash—Pilocarpine—glaucoma	0.000195	0.00101	CcSEcCtD
Mifepristone—Dermatitis—Pilocarpine—glaucoma	0.000195	0.00101	CcSEcCtD
Mifepristone—Insomnia—Betaxolol—glaucoma	0.000195	0.00101	CcSEcCtD
Mifepristone—Nausea—Dorzolamide—glaucoma	0.000195	0.00101	CcSEcCtD
Mifepristone—Headache—Pilocarpine—glaucoma	0.000194	0.00101	CcSEcCtD
Mifepristone—Nausea—Travoprost—glaucoma	0.000194	0.00101	CcSEcCtD
Mifepristone—Dyspnoea—Betaxolol—glaucoma	0.000192	0.000997	CcSEcCtD
Mifepristone—Nausea—Brinzolamide—glaucoma	0.000191	0.000994	CcSEcCtD
Mifepristone—Decreased appetite—Betaxolol—glaucoma	0.000187	0.000973	CcSEcCtD
Mifepristone—Hypertension—Timolol—glaucoma	0.000186	0.000967	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Betaxolol—glaucoma	0.000186	0.000966	CcSEcCtD
Mifepristone—Fatigue—Betaxolol—glaucoma	0.000186	0.000965	CcSEcCtD
Mifepristone—Pain—Betaxolol—glaucoma	0.000184	0.000957	CcSEcCtD
Mifepristone—Constipation—Betaxolol—glaucoma	0.000184	0.000957	CcSEcCtD
Mifepristone—Nausea—Pilocarpine—glaucoma	0.000184	0.000956	CcSEcCtD
Mifepristone—Myalgia—Timolol—glaucoma	0.000184	0.000953	CcSEcCtD
Mifepristone—Arthralgia—Timolol—glaucoma	0.000184	0.000953	CcSEcCtD
Mifepristone—Anxiety—Timolol—glaucoma	0.000183	0.00095	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000182	0.000947	CcSEcCtD
Mifepristone—Hypersensitivity—Clonidine—glaucoma	0.000182	0.000947	CcSEcCtD
Mifepristone—Discomfort—Timolol—glaucoma	0.000181	0.000942	CcSEcCtD
Mifepristone—Dry mouth—Timolol—glaucoma	0.00018	0.000932	CcSEcCtD
Mifepristone—Asthenia—Clonidine—glaucoma	0.000177	0.000922	CcSEcCtD
Mifepristone—Feeling abnormal—Betaxolol—glaucoma	0.000177	0.000922	CcSEcCtD
Mifepristone—Oedema—Timolol—glaucoma	0.000176	0.000914	CcSEcCtD
Mifepristone—Pruritus—Clonidine—glaucoma	0.000175	0.000909	CcSEcCtD
Mifepristone—Infection—Timolol—glaucoma	0.000175	0.000908	CcSEcCtD
Mifepristone—Nervous system disorder—Timolol—glaucoma	0.000173	0.000896	CcSEcCtD
Mifepristone—Urticaria—Betaxolol—glaucoma	0.000171	0.000889	CcSEcCtD
Mifepristone—Skin disorder—Timolol—glaucoma	0.000171	0.000888	CcSEcCtD
Mifepristone—Body temperature increased—Betaxolol—glaucoma	0.00017	0.000884	CcSEcCtD
Mifepristone—Diarrhoea—Clonidine—glaucoma	0.000169	0.000879	CcSEcCtD
Mifepristone—Anorexia—Timolol—glaucoma	0.000168	0.000871	CcSEcCtD
Mifepristone—Hypotension—Timolol—glaucoma	0.000164	0.000854	CcSEcCtD
Mifepristone—Dizziness—Clonidine—glaucoma	0.000164	0.00085	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Timolol—glaucoma	0.00016	0.000833	CcSEcCtD
Mifepristone—Insomnia—Timolol—glaucoma	0.000159	0.000827	CcSEcCtD
Mifepristone—Hypersensitivity—Betaxolol—glaucoma	0.000159	0.000824	CcSEcCtD
Mifepristone—Vomiting—Clonidine—glaucoma	0.000157	0.000817	CcSEcCtD
Mifepristone—Dyspnoea—Timolol—glaucoma	0.000157	0.000815	CcSEcCtD
Mifepristone—Somnolence—Timolol—glaucoma	0.000156	0.000813	CcSEcCtD
Mifepristone—Rash—Clonidine—glaucoma	0.000156	0.00081	CcSEcCtD
Mifepristone—Dermatitis—Clonidine—glaucoma	0.000156	0.000809	CcSEcCtD
Mifepristone—Headache—Clonidine—glaucoma	0.000155	0.000805	CcSEcCtD
Mifepristone—Asthenia—Betaxolol—glaucoma	0.000155	0.000803	CcSEcCtD
Mifepristone—Decreased appetite—Timolol—glaucoma	0.000153	0.000794	CcSEcCtD
Mifepristone—Pruritus—Betaxolol—glaucoma	0.000152	0.000792	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Timolol—glaucoma	0.000152	0.000789	CcSEcCtD
Mifepristone—Fatigue—Timolol—glaucoma	0.000152	0.000788	CcSEcCtD
Mifepristone—Pain—Timolol—glaucoma	0.00015	0.000782	CcSEcCtD
Mifepristone—Diarrhoea—Betaxolol—glaucoma	0.000147	0.000765	CcSEcCtD
Mifepristone—Nausea—Clonidine—glaucoma	0.000147	0.000763	CcSEcCtD
Mifepristone—Feeling abnormal—Timolol—glaucoma	0.000145	0.000753	CcSEcCtD
Mifepristone—Gastrointestinal pain—Timolol—glaucoma	0.000144	0.000747	CcSEcCtD
Mifepristone—Dizziness—Betaxolol—glaucoma	0.000142	0.00074	CcSEcCtD
Mifepristone—Urticaria—Timolol—glaucoma	0.00014	0.000726	CcSEcCtD
Mifepristone—Abdominal pain—Timolol—glaucoma	0.000139	0.000723	CcSEcCtD
Mifepristone—Body temperature increased—Timolol—glaucoma	0.000139	0.000723	CcSEcCtD
Mifepristone—Vomiting—Betaxolol—glaucoma	0.000137	0.000711	CcSEcCtD
Mifepristone—Rash—Betaxolol—glaucoma	0.000136	0.000705	CcSEcCtD
Mifepristone—Dermatitis—Betaxolol—glaucoma	0.000136	0.000705	CcSEcCtD
Mifepristone—Headache—Betaxolol—glaucoma	0.000135	0.000701	CcSEcCtD
Mifepristone—Hypersensitivity—Timolol—glaucoma	0.00013	0.000673	CcSEcCtD
Mifepristone—Nausea—Betaxolol—glaucoma	0.000128	0.000665	CcSEcCtD
Mifepristone—Asthenia—Timolol—glaucoma	0.000126	0.000656	CcSEcCtD
Mifepristone—Pruritus—Timolol—glaucoma	0.000124	0.000647	CcSEcCtD
Mifepristone—Diarrhoea—Timolol—glaucoma	0.00012	0.000625	CcSEcCtD
Mifepristone—Dizziness—Timolol—glaucoma	0.000116	0.000604	CcSEcCtD
Mifepristone—Vomiting—Timolol—glaucoma	0.000112	0.000581	CcSEcCtD
Mifepristone—Rash—Timolol—glaucoma	0.000111	0.000576	CcSEcCtD
Mifepristone—Dermatitis—Timolol—glaucoma	0.000111	0.000576	CcSEcCtD
Mifepristone—Headache—Timolol—glaucoma	0.00011	0.000573	CcSEcCtD
Mifepristone—Nausea—Timolol—glaucoma	0.000105	0.000543	CcSEcCtD
Mifepristone—CYP3A5—Oxidation by Cytochrome P450—CYP1B1—glaucoma	9.7e-05	0.00537	CbGpPWpGaD
Mifepristone—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	9.57e-05	0.0053	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—NTRK2—glaucoma	9.51e-05	0.00526	CbGpPWpGaD
Mifepristone—AR—Notch-mediated HES/HEY network—CDKN1B—glaucoma	9.44e-05	0.00523	CbGpPWpGaD
Mifepristone—NR3C1—Transcription factor regulation in adipogenesis—TNF—glaucoma	9.37e-05	0.00519	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—glaucoma	9.15e-05	0.00507	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	8.84e-05	0.00489	CbGpPWpGaD
Mifepristone—AR—Coregulation of Androgen receptor activity—CDKN2A—glaucoma	8.66e-05	0.00479	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—CAV1—glaucoma	8.65e-05	0.00479	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—MMP1—glaucoma	8.3e-05	0.00459	CbGpPWpGaD
Mifepristone—CYP2D6—Melatonin metabolism and effects—APOE—glaucoma	8.23e-05	0.00455	CbGpPWpGaD
Mifepristone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	8.18e-05	0.00453	CbGpPWpGaD
Mifepristone—ABCC1—Arachidonic acid metabolism—PTGS2—glaucoma	8.13e-05	0.0045	CbGpPWpGaD
Mifepristone—CYP3A5—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	7.97e-05	0.00441	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—glaucoma	7.61e-05	0.00421	CbGpPWpGaD
Mifepristone—CYP3A7—Biological oxidations—GSTT1—glaucoma	7.35e-05	0.00407	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—glaucoma	7.31e-05	0.00405	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—SLC4A4—glaucoma	7.24e-05	0.00401	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—NTRK2—glaucoma	7.21e-05	0.00399	CbGpPWpGaD
Mifepristone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	7.2e-05	0.00398	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—BDNF—glaucoma	7.1e-05	0.00393	CbGpPWpGaD
Mifepristone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	6.99e-05	0.00387	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—glaucoma	6.97e-05	0.00386	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—BAD—glaucoma	6.96e-05	0.00385	CbGpPWpGaD
Mifepristone—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	6.9e-05	0.00382	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—IL1A—glaucoma	6.81e-05	0.00377	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	6.59e-05	0.00365	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—NGF—glaucoma	6.3e-05	0.00348	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	6.27e-05	0.00347	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—NR3C1—glaucoma	6.27e-05	0.00347	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	6.07e-05	0.00336	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	6.04e-05	0.00334	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—MMP1—glaucoma	5.91e-05	0.00327	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—NARFL—glaucoma	5.91e-05	0.00327	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CA5A—glaucoma	5.91e-05	0.00327	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—CDKN2A—glaucoma	5.88e-05	0.00326	CbGpPWpGaD
Mifepristone—CYP3A7—Biological oxidations—CYP1B1—glaucoma	5.86e-05	0.00324	CbGpPWpGaD
Mifepristone—CYP3A7—Metapathway biotransformation—CYP1B1—glaucoma	5.78e-05	0.0032	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—LRP12—glaucoma	5.73e-05	0.00317	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—glaucoma	5.72e-05	0.00316	CbGpPWpGaD
Mifepristone—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.67e-05	0.00314	CbGpPWpGaD
Mifepristone—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	5.65e-05	0.00313	CbGpPWpGaD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	5.56e-05	0.00308	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—BDNF—glaucoma	5.38e-05	0.00298	CbGpPWpGaD
Mifepristone—ABCC1—Disease—LRP12—glaucoma	5.34e-05	0.00296	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—BAD—glaucoma	5.33e-05	0.00295	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—FAS—glaucoma	5.33e-05	0.00295	CbGpPWpGaD
Mifepristone—CYP3A5—Biological oxidations—GSTT1—glaucoma	5.31e-05	0.00294	CbGpPWpGaD
Mifepristone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—glaucoma	5.22e-05	0.00289	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—CDKN1B—glaucoma	5.21e-05	0.00288	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—IL1A—glaucoma	5.17e-05	0.00286	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	5.16e-05	0.00286	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—NARFL—glaucoma	5.15e-05	0.00285	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CA5A—glaucoma	5.15e-05	0.00285	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	5.1e-05	0.00282	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—CDKN1B—glaucoma	4.85e-05	0.00268	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—SLC6A13—glaucoma	4.83e-05	0.00267	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—MMP9—glaucoma	4.83e-05	0.00267	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IL1A—glaucoma	4.79e-05	0.00265	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—NGF—glaucoma	4.78e-05	0.00264	CbGpPWpGaD
Mifepristone—CYP3A7—Biological oxidations—GSTM1—glaucoma	4.68e-05	0.00259	CbGpPWpGaD
Mifepristone—CYP3A7—Metapathway biotransformation—GSTM1—glaucoma	4.62e-05	0.00255	CbGpPWpGaD
Mifepristone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	4.57e-05	0.00253	CbGpPWpGaD
Mifepristone—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	4.51e-05	0.0025	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	4.42e-05	0.00244	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—FAS—glaucoma	4.27e-05	0.00236	CbGpPWpGaD
Mifepristone—CYP3A5—Biological oxidations—CYP1B1—glaucoma	4.23e-05	0.00234	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—C3—glaucoma	4.21e-05	0.00233	CbGpPWpGaD
Mifepristone—CYP3A5—Metapathway biotransformation—CYP1B1—glaucoma	4.17e-05	0.00231	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—OPN4—glaucoma	3.97e-05	0.0022	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—CDKN2B—glaucoma	3.96e-05	0.00219	CbGpPWpGaD
Mifepristone—CYP2D6—Biological oxidations—GSTT1—glaucoma	3.78e-05	0.00209	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—NARFL—glaucoma	3.72e-05	0.00206	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CA5A—glaucoma	3.72e-05	0.00206	CbGpPWpGaD
Mifepristone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	3.72e-05	0.00206	CbGpPWpGaD
Mifepristone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	3.7e-05	0.00205	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HEYL—glaucoma	3.69e-05	0.00204	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	3.6e-05	0.00199	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PTGFR—glaucoma	3.58e-05	0.00198	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—SLC6A1—glaucoma	3.54e-05	0.00196	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—NR3C1—glaucoma	3.48e-05	0.00192	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	3.45e-05	0.00191	CbGpPWpGaD
Mifepristone—ABCC1—Disease—FGFR1OP—glaucoma	3.44e-05	0.00191	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HEYL—glaucoma	3.44e-05	0.00191	CbGpPWpGaD
Mifepristone—CYP3A5—Biological oxidations—GSTM1—glaucoma	3.38e-05	0.00187	CbGpPWpGaD
Mifepristone—CYP3A5—Metapathway biotransformation—GSTM1—glaucoma	3.34e-05	0.00185	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—TP53—glaucoma	3.27e-05	0.00181	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	3.25e-05	0.0018	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—VEGFA—glaucoma	3.09e-05	0.00171	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	3.08e-05	0.0017	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—CDKN2B—glaucoma	3.02e-05	0.00167	CbGpPWpGaD
Mifepristone—CYP2D6—Biological oxidations—CYP1B1—glaucoma	3.01e-05	0.00167	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—VEGFA—glaucoma	3.01e-05	0.00166	CbGpPWpGaD
Mifepristone—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	2.97e-05	0.00164	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—TP53—glaucoma	2.88e-05	0.0016	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CA1—glaucoma	2.88e-05	0.0016	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NARFL—glaucoma	2.81e-05	0.00155	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CA5A—glaucoma	2.81e-05	0.00155	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—RPTOR—glaucoma	2.8e-05	0.00155	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CTSA—glaucoma	2.79e-05	0.00155	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NCK2—glaucoma	2.71e-05	0.0015	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	2.69e-05	0.00149	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—NR3C1—glaucoma	2.65e-05	0.00147	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CA5A—glaucoma	2.65e-05	0.00147	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NARFL—glaucoma	2.65e-05	0.00147	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CA2—glaucoma	2.64e-05	0.00146	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.58e-05	0.00143	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.58e-05	0.00143	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—TNF—glaucoma	2.58e-05	0.00143	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	2.56e-05	0.00142	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CA1—glaucoma	2.52e-05	0.00139	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	2.48e-05	0.00137	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—GSTT1—glaucoma	2.47e-05	0.00137	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	2.46e-05	0.00136	CbGpPWpGaD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	2.44e-05	0.00135	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CTSA—glaucoma	2.44e-05	0.00135	CbGpPWpGaD
Mifepristone—CYP2D6—Biological oxidations—GSTM1—glaucoma	2.41e-05	0.00133	CbGpPWpGaD
Mifepristone—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	2.37e-05	0.00131	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—TP53—glaucoma	2.33e-05	0.00129	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HDAC9—glaucoma	2.31e-05	0.00128	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CA2—glaucoma	2.3e-05	0.00127	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	2.3e-05	0.00127	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—CDKN2B—glaucoma	2.29e-05	0.00127	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—VEGFA—glaucoma	2.28e-05	0.00126	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—TNF—glaucoma	2.26e-05	0.00125	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.19e-05	0.00121	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HDAC9—glaucoma	2.15e-05	0.00119	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—VEGFA—glaucoma	2.11e-05	0.00117	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	2.11e-05	0.00116	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—CYP1B1—glaucoma	1.97e-05	0.00109	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—TNF—glaucoma	1.96e-05	0.00108	CbGpPWpGaD
Mifepristone—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	1.94e-05	0.00107	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.93e-05	0.00107	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—CDKN2B—glaucoma	1.91e-05	0.00106	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—TXN—glaucoma	1.86e-05	0.00103	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CA1—glaucoma	1.82e-05	0.00101	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—TNF—glaucoma	1.81e-05	0.001	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SMO—glaucoma	1.8e-05	0.000998	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	1.8e-05	0.000996	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CTSA—glaucoma	1.76e-05	0.000974	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CA5A—glaucoma	1.73e-05	0.000958	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NARFL—glaucoma	1.73e-05	0.000958	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.7e-05	0.000938	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	1.68e-05	0.000931	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.68e-05	0.00093	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—NR3C1—glaucoma	1.67e-05	0.000926	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CA2—glaucoma	1.66e-05	0.00092	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NTRK2—glaucoma	1.65e-05	0.000913	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—TXN—glaucoma	1.62e-05	0.000897	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—GSTM1—glaucoma	1.57e-05	0.000871	CbGpPWpGaD
Mifepristone—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	1.55e-05	0.000859	CbGpPWpGaD
Mifepristone—AR—Gene Expression—CDKN2B—glaucoma	1.45e-05	0.000804	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GSTT1—glaucoma	1.44e-05	0.000797	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NGFR—glaucoma	1.42e-05	0.000783	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CA1—glaucoma	1.37e-05	0.000759	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NTRK1—glaucoma	1.35e-05	0.000744	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CTSA—glaucoma	1.33e-05	0.000735	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	1.32e-05	0.000733	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CA1—glaucoma	1.29e-05	0.000715	CbGpPWpGaD
Mifepristone—AR—Gene Expression—NR3C1—glaucoma	1.27e-05	0.000705	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GSTT1—glaucoma	1.26e-05	0.000695	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CA2—glaucoma	1.25e-05	0.000694	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	1.25e-05	0.000694	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CTSA—glaucoma	1.25e-05	0.000693	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CDKN2B—glaucoma	1.24e-05	0.000686	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EDN1—glaucoma	1.19e-05	0.000658	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CA2—glaucoma	1.18e-05	0.000654	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—TXN—glaucoma	1.17e-05	0.000648	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.16e-05	0.000643	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CDKN2B—glaucoma	1.16e-05	0.000639	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ABCA1—glaucoma	1.15e-05	0.000635	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CYP1B1—glaucoma	1.15e-05	0.000635	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—CDKN2B—glaucoma	1.1e-05	0.00061	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NGF—glaucoma	1.09e-05	0.000605	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.04e-05	0.000577	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—C3—glaucoma	1.04e-05	0.000575	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CYP1B1—glaucoma	1e-05	0.000554	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ABCA1—glaucoma	1e-05	0.000554	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MTHFR—glaucoma	9.69e-06	0.000536	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—APOE—glaucoma	9.68e-06	0.000535	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CAV1—glaucoma	9.59e-06	0.00053	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GSTM1—glaucoma	9.18e-06	0.000508	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—FN1—glaucoma	9.12e-06	0.000505	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GSTT1—glaucoma	9.09e-06	0.000503	CbGpPWpGaD
Mifepristone—ABCC1—Disease—APOE—glaucoma	9.02e-06	0.000499	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—BAD—glaucoma	9.02e-06	0.000499	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	8.94e-06	0.000495	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CAV1—glaucoma	8.94e-06	0.000494	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—TXN—glaucoma	8.84e-06	0.000489	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CA1—glaucoma	8.45e-06	0.000468	CbGpPWpGaD
Mifepristone—ABCC1—Disease—BAD—glaucoma	8.4e-06	0.000465	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—TXN—glaucoma	8.33e-06	0.000461	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CTSA—glaucoma	8.19e-06	0.000453	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—MTHFR—glaucoma	8.11e-06	0.000449	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GSTM1—glaucoma	8.01e-06	0.000443	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	7.88e-06	0.000436	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CA2—glaucoma	7.73e-06	0.000428	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—APOE—glaucoma	7.55e-06	0.000418	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CAV1—glaucoma	7.48e-06	0.000414	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NOS3—glaucoma	7.25e-06	0.000401	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP1B1—glaucoma	7.24e-06	0.000401	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ABCA1—glaucoma	7.24e-06	0.000401	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—MTHFR—glaucoma	7.08e-06	0.000392	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTT1—glaucoma	6.86e-06	0.000379	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NOS3—glaucoma	6.76e-06	0.000374	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—APOE—glaucoma	6.59e-06	0.000364	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CAV1—glaucoma	6.53e-06	0.000361	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTT1—glaucoma	6.46e-06	0.000357	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CDKN1B—glaucoma	6.28e-06	0.000347	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTGS2—glaucoma	6.18e-06	0.000342	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CDKN1B—glaucoma	5.85e-06	0.000324	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MMP9—glaucoma	5.82e-06	0.000322	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GSTM1—glaucoma	5.79e-06	0.00032	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—NOS3—glaucoma	5.66e-06	0.000313	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ABCA1—glaucoma	5.46e-06	0.000302	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP1B1—glaucoma	5.46e-06	0.000302	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—TXN—glaucoma	5.45e-06	0.000301	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—VEGFA—glaucoma	5.22e-06	0.000289	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTGS2—glaucoma	5.17e-06	0.000286	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ABCA1—glaucoma	5.15e-06	0.000285	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP1B1—glaucoma	5.15e-06	0.000285	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—MTHFR—glaucoma	5.11e-06	0.000283	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—NOS3—glaucoma	4.93e-06	0.000273	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—APOE—glaucoma	4.76e-06	0.000263	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CAV1—glaucoma	4.72e-06	0.000261	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTGS2—glaucoma	4.51e-06	0.00025	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTM1—glaucoma	4.37e-06	0.000242	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTT1—glaucoma	4.22e-06	0.000234	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTM1—glaucoma	4.12e-06	0.000228	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TP53—glaucoma	3.95e-06	0.000218	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—MTHFR—glaucoma	3.86e-06	0.000214	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—MTHFR—glaucoma	3.64e-06	0.000201	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—APOE—glaucoma	3.59e-06	0.000199	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—NOS3—glaucoma	3.57e-06	0.000197	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CAV1—glaucoma	3.56e-06	0.000197	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—APOE—glaucoma	3.39e-06	0.000187	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ABCA1—glaucoma	3.37e-06	0.000186	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP1B1—glaucoma	3.37e-06	0.000186	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CAV1—glaucoma	3.35e-06	0.000186	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTGS2—glaucoma	3.26e-06	0.000181	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NOS3—glaucoma	2.69e-06	0.000149	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTM1—glaucoma	2.69e-06	0.000149	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NOS3—glaucoma	2.54e-06	0.00014	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTGS2—glaucoma	2.46e-06	0.000136	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—MTHFR—glaucoma	2.38e-06	0.000132	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTGS2—glaucoma	2.32e-06	0.000128	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—APOE—glaucoma	2.21e-06	0.000122	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CAV1—glaucoma	2.19e-06	0.000121	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NOS3—glaucoma	1.66e-06	9.18e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTGS2—glaucoma	1.52e-06	8.39e-05	CbGpPWpGaD
